Xufang Dai

Xufang Dai

Auto-generated profile, based on publicly available information

Xufang Dai

College of Education and Science, Chongqing Normal University, Chongqing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in Science Advances
Verified
Journal Article
Open access
LSLiangbo Sun
Liangbo Sun
HXHaojun Xiong
Haojun Xiong
LCLingxi Chen
Lingxi Chen
XDXufang Dai
Xufang Dai
XYXiaojing Yan
Xiaojing Yan
JLJiqin Lian
Jiqin Lian
Eukaryotes initiate autophagy when facing environmental changes such as a lack of external nutrients. However, the mechanisms of autophagy initiation are still not fully elucidated. Here, we showed that deacetylation of ATG4B plays a key role in starvation-induced autophagy initiation. Specifically, we demonstrated that ATG4B is activated during starvation through deacetylation at K39 by the deacetylase SIRT2. Moreover, starvation triggers SIRT2 dephosphorylation and activation in a cyclin E/CDK2 suppression–dependent manner. Meanwhile, starvation down-regulates p300, leading to a decrease in ATG4B acetylation at K39. K39 deacetylation also enhances the interaction of ATG4B with pro-LC3, which promotes LC3-II formation. Furthermore, an in vivo experiment using Sirt2 knockout mice also confirmed that SIRT2-mediated ATG4B deacetylation at K39 promotes starvation-induced autophagy initiation. In summary, this study reveals an acetylation-dependent regulatory mechanism that controls the role of ATG4B in autophagy initiation in response to nutritional deficiency.

8 March 2024 in Autophagy
Verified
Journal Article
Closed access
YWYaran Wu
Yaran Wu
YCYang Chen
Yang Chen
XYXiaojing Yan
Xiaojing Yan
XDXufang Dai
Xufang Dai
YLYaling Liao
Yaling Liao
JLJiqin Lian
Jiqin Lian

30 September 2025 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
DNDun Niu
Dun Niu
SZShaotong Zhang
Shaotong Zhang
XMXiaozhuang Ma
Xiaozhuang Ma
YWYaran Wu
Yaran Wu
JZJunshi Zhu
Junshi Zhu
JLJiqin Lian
Jiqin Lian
Gene-directed enzyme prodrug therapy represents a promising antitumor strategy owing to its low systemic toxicity. However, clinical translation has been hindered by challenges in suicide gene delivery. Artificially engineered circular RNA (circRNA) demonstrates exceptional potential for gene delivery when combined with lipid nanoparticle technology, exhibiting high stability, prolonged protein-coding capacity, and cost-effective production. We developed an in vitro synthesized circRNA encoding the cytosine deaminase–uracil phosphoribosyltransferase (circCDUPRT). Upon intratumoral administration, circCDUPRT achieved sustained intratumoral expression with minimal systemic toxicity. The combination of circCDUPRT and prodrug 5-fluorocytosine showed significant antitumor efficacy in both in vitro and in vivo tumor models. In advanced melanoma models, combining circCDUPRT/5-fluorocytosine with IL-15–expressing circRNA potently enhanced the expansion and activation of CD8+ T and NK cells. Collectively, these findings establish the synthetic circRNA platform as a cost-effective, high-efficiency delivery system for gene-directed enzyme prodrug therapy and immunotherapy applications.